10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q1 2017

Filing Information

Form Type	10-Q
Accession Number	`0001144204-17-026081`
Period End Date	20170331
Filing Date	20170510
Fiscal Year	2017
Fiscal Period	Q1
XBRL Instance	bpth-20170331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 22 Cash Flow Statement 34

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$9.38M	USD	Point-in-time
Cash	`Cash`	$7.11M	USD	Point-in-time
Cash	`Cash`	$8.85M	USD	Point-in-time
Cash	`Cash`	$6.47M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$377.00K	USD	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$376.00K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$902.00K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$862.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.65M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$8.35M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	95.64M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	95.64M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$708.00K	USD	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$999.00K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	95.64M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	95.64M	shares	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$94.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$127.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$872.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$614.00K	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Less accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.61M	USD	Point-in-time
Less accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.57M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$889.00K	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$929.00K	USD	Point-in-time
Total Assets	`Assets`	$10.11M	USD	Point-in-time
Total Assets	`Assets`	$12.20M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$69.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$89.00K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$608.00K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$969.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$12.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$12.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$709.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.05M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.91M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$1.31M	USD	Point-in-time
Total Liabilities	`Liabilities`	$2.02M	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.96M	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 95,645 and 95,645 shares issued and outstanding, respectively	`CommonStockValue`	$96.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 95,645 and 95,645 shares issued and outstanding, respectively	`CommonStockValue`	$96.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$40.53M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$40.28M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-32.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-32.13M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$8.24M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$8.09M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$10.11M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$12.20M	USD	Point-in-time

Income Statement 22 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.02M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.03M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$970.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$849.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.87M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.00M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.87M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-2.00M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.60M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$3.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$2.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$1.60M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-397.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.87M	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	95.64M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.76M	shares	1 Quarter

Cash Flow Statement 34 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-397.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.87M	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$40.00K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$40.00K	USD	1 Quarter
Depreciation	`Depreciation`	$10.00K	USD	1 Quarter
Depreciation	`Depreciation`	$33.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$249.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$95.00K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.60M	USD	1 Quarter
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$51.00K	USD	1 Quarter
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$1.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$571.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-40.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-37.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-208.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-1.84M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.38M	USD	1 Quarter
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$424.00K	USD	1 Quarter
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-424.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	-	USD	1 Quarter
Net decrease in cash	`CashPeriodIncreaseDecrease`	$-2.26M	USD	1 Quarter
Net decrease in cash	`CashPeriodIncreaseDecrease`	$-2.38M	USD	1 Quarter
Cash, beginning of period	`Cash`	$9.38M	USD	Point-in-time
Cash, beginning of period	`Cash`	$7.11M	USD	Point-in-time
Cash, beginning of period	`Cash`	$8.85M	USD	Point-in-time
Cash, beginning of period	`Cash`	$6.47M	USD	Point-in-time
Cash, end of period	`Cash`	$9.38M	USD	Point-in-time
Cash, end of period	`Cash`	$7.11M	USD	Point-in-time
Cash, end of period	`Cash`	$8.85M	USD	Point-in-time
Cash, end of period	`Cash`	$6.47M	USD	Point-in-time
Capital expenditures included in accrued expense	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	1 Quarter
Capital expenditures included in accrued expense	`CapitalExpendituresIncurredButNotYetPaid`	$114.00K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.